Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 22, 2005

Primary Completion Date

October 4, 2006

Study Completion Date

April 24, 2008

Conditions
Myocardial Infarction
Interventions
BIOLOGICAL

Provacel

ex vivo cultured adult mesenchymal stem cells

BIOLOGICAL

Placebo

Placebo

Trial Locations (15)

10032

Columbia Presbyterian Hospital, New York

14642

University of Rochester - Strong Memorial, Rochester

19104

University of Pennsylvania Medical Center, Philadelphia

20010

Washington Hospital Center, Washington D.C.

20912

Washington Adventist, Takoma Park

21205

Johns Hopkins University, Baltimore

40202

Jewish Hospital, Louisville

46260

The Care Group, Indianapolis

55407

Minneapolis Heart Institute, Minneapolis

60612

Rush University Medical Center, Chicago

73104

University of Oklahoma Health Sciences Center, Oklahoma City

77030

Texas Medical School, Houston

78756

Austin Heart Institute, Austin

85006

Arizona Heart Institute, Phoenix

92103-8411

University of California - San Diego; Thornton, San Diego

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mesoblast, Inc.

INDUSTRY